WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 7'7301 Infant (under 12 months) mortality rate: 412
GDP / capita (US$): 15'6751 Child (under 5 years) mortality rate: 532

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 2'021  2'004  1'987  1'969  1'952  1'755  1'384  998 
Births 48  48  48  48  48  48  48  44 
Surviving infants 46  46  46  46  46  45  45  41 
Pop. less than 5 years 232  232  232  230  229  227  225  188 
Pop. less than 15 years 677  677  676  675  674  673  620  464 
Female 15-49 years 535  530  526  522  517  457  323  229 

Number of reported case

(Click for retrospective incidence data for Botswana)
Diphtheria
Japanese encephalitis
Measles 853  184  2'672  1'218  4'091 
Mumps
Pertussis 22  110 
Polio*
Rubella 121  163  214  13  170 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Botswana)
Vaccine year result method % card seen                                                
BCG 2006  99  EPI   98  99*  99*  99*  99*  99*  73 
DTP1 2006  98  EPI   98  99*  99*  99*  99*  99*  94 
DTP3 2006  96  EPI   98  79  99*  99*  95  97  85 
HepB_BD          100  99*  99*  99*  87  86 
HepB3 2006  93  EPI   98  99*  99*  82  86  73 
Hib3          99*  99* 
JapEnc         
MCV 2006  94  EPI   98  93  99*  99*  94  93  84 
MCV2          82 
PCV1          99*  99* 
PCV3          65  52 
Pol3 2006  96  EPI   98  86  98  99*  99*  83  85 
Rota1          96  99* 
Rota_last          78  74 
Rubella1         
TT2plus 2006  69  EPI   98  70  79  81  64  70  45 
PAB         
VAD1          79  90  99*  99* 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Botswana)
BCG 99  99  99  99  99  99  93  92 
DTP1 98  98  98  98  98  98  99  89 
DTP3 96  96  96  96  96  97  92  71 
HepB3 96  96  96  95  95  86 
HepB_BD 99  99  99  99  99  99 
Hib3 96  96  96 
MCV 94  94  94  94  94  91  87  63 
MCV2 83 
PAB 92  92  92  92  92  80  59 
PCV3 65  52 
Pol3 96  96  96  96  96  97  90  46 
Rota_last 78  74 

Number of districts in the country 24  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 33
From 80 to 89% 25
From 50 to 79% 42
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 18 months; 7 years;
DTwPHibHepB 2, 3, 4 months; Yes
HepB birth; Yes
Measles 9, 18 months; Yes
OPV 2, 3, 4, 18 months; 7 years; Yes
Pneumo_conj 2, 3, 4 months; Yes
Rotavirus 2, 3 months; Yes
TT 1st contact pregnancy; +4 weeks; +6 months; +1, +1 year; Yes
VitaminA 6-11, 12-59 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012- 2016  2011-2015  2011-2015  2006-2010  2006-2010  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 24  24  24  24 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No       

System performance

Total Nº districts in country number 24  24  24  24  24  24  24 
Nº districts with DTP3 coverage >=80% number 14  18  17  22  23  23 
% of districts with DTP3 coverage >=80% From 0 to 100% 58  75  71  92  96  96  17 
Nº districts with measles (MCV1) coverage >=95% number 12  16  16  14  11  13   
% of districts with MCV1 coverage >=95% From 0 to 100% 50  67  67  58  46  54   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No    No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes        No  No  No 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100    100  100  100  100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.